Ionpath is a pioneer in high-resolution spatial proteomics, revolutionizing tissue imaging and analysis to accelerate medical discovery and improve human health. Its MIBI™ (multiplexed ion beam imaging) platform breaks through the limitations of traditional immunohistochemistry (IHC), enabling a deeper understanding of the tissue microenvironment with highly multiplexed, quantitative, spatial single-cell analysis. With MIBI technology and the expertise of its pathology/data science teams, Ionpath delivers actionable insights for translational researchers at top pharma, biotech, and research organizations in immuno-oncology, immunology, neuroscience, and infectious disease.